Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interferon alpha-2b

Next Previous
Drug Profile

Interferon alpha-2b

Alternative Names: Intron A; SCH 30500; Viraferon; Virtron; YM 14090

Latest Information Update: 05 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biogen Idec
  • Developer Biogen; Merck & Co
  • Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
  • Mechanism of Action Interferon alpha stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Chronic myeloid leukaemia; Follicular lymphoma; Hairy cell leukaemia; Hepatitis B; Hepatitis C; Human papillomavirus infections; Malignant melanoma; Multiple myeloma; Non-Hodgkin's lymphoma

Most Recent Events

  • 13 Jun 2018 Merk prematurely terminates a phase II/III trial in Melanoma (Adjuvant therapy, Late-stage disease, Metastatic disease) due to sub-optimal accrual (SC, IV) (NCT03552549)
  • 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
  • 17 Nov 2003 IDEC Pharmaceuticals has merged with Biogen to form Biogen Idec

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top